A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design

References

• Russell DG, Barry CE3rd, Flynn JL. Tuberculosis: what we don’t know can, and does, hurt us. Science 2010;328(5980):852-6
   PubMed Web of Science ®Google Scholar
• Andersen P, Doherty TM. The success and failure of BCG implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005;3(8):656-62
   PubMed Web of Science ®Google Scholar
• Young D, Dye C. The development and impact of tuberculosis vaccines. Cell 2006;124(4):683-7
   PubMed Web of Science ®Google Scholar
• Bansal K, Elluru SR, Narayana Y, et al. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J Immunol 2010;184(7):3495-504
   PubMed Web of Science ®Google Scholar
• Gagliardi MC, Teloni R, Mariotti S, et al. Bacillus Calmette-Guérin shares with virulent Mycobacterium tuberculosis the capacity to subvert monocyte differentiation into dendritic cell: implication for its efficacy as a vaccine preventing tuberculosis. Vaccine 2004;22(29-30):3848-57
   PubMed Web of Science ®Google Scholar
• Dietrich G, Viret JF, Hess J. Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments. Vaccine 2003;21(7-8):667-70
   PubMed Web of Science ®Google Scholar
• Brosch R, Gordon SV, Garnier T, et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 2007;104(13):5596-601
   PubMed Web of Science ®Google Scholar
• Davies DH, Halablab MA, Young TWK, et al. Infection and immunity (Modules in Life Sciences Series). Taylor and Francis; CRC Press, Ltd; USA: 1999
   Google Scholar
• Grover A, Ahmed MF, Verma I, et al. Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model. Protein Expr Purif 2006;48(2):274-80
   PubMed Web of Science ®Google Scholar
• Girard MP, Fruth U, Kieny MP. A review of vaccine research and development: tuberculosis. Vaccine 2005;23(50):5725-31
   PubMed Web of Science ®Google Scholar
• Parida SK, Kaufmann SH. Novel tuberculosis vaccines on the horizon. Curr Opin Immunol 2010;22(3):374-84
   PubMed Web of Science ®Google Scholar
• McShane H, Pathan AA, Sander CR, et al. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis (Edinb) 2005;85(1-2):47-52
   PubMed Web of Science ®Google Scholar
• Andersen P. Vaccine strategies against latent tuberculosis infection. Trends Microbiol 2007;15(1):7-13
   PubMed Web of Science ®Google Scholar
• Rudensky AYu, Preston-Hurlburt P, Hong SC, et al. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991;353(6345):622-7
   PubMed Web of Science ®Google Scholar
• Turner MJ, Abdul-Alim CS, Willis RA, et al. T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes. J Immunol Methods 2001;256(1-2):107-19
   PubMed Web of Science ®Google Scholar
• Halling-Brown M, Sansom CE, Davies M, et al. Are bacterial vaccine antigens T-cell epitope depleted? Trends Immunol 2008;29(8):374-9
   PubMed Web of Science ®Google Scholar
• Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 2001;19(17-19):2688-91
   PubMed Web of Science ®Google Scholar
• Sette A, Peters B. Immune epitope mapping in the post-genomic era: lessons for vaccine development. Curr Opin Immunol 2007;19(1):106-10
   PubMed Web of Science ®Google Scholar
• Kanampalliwar AM, Rajkumar S, Girdhar A, Archana T. Reverse Vaccinology: basics and applications. J Vaccines Vaccin 2013;4:194
   Google Scholar
• Rasmussen IB, Lunde E, Michaelsen TE, et al. The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination. Proc Natl Acad Sci USA 2001;98(18):10296-301
   PubMed Web of Science ®Google Scholar
• Evans TG, Brennan MJ, Barker L, Thole J. Preventive vaccines for tuberculosis. Vaccine 2013;31(Suppl 2):B223-6
   PubMedGoogle Scholar
• Rowland R, McShane H. Tuberculosis vaccines in clinical trials. Expert Rev Vaccines 2011;10(5):645-58
   PubMed Web of Science ®Google Scholar
• Marinova D, Gonzalo-Asensio J, Aguilo N, Martin C. Recent developments in tuberculosis vaccines. Expert Rev Vaccines 2013;12(12):1431-48
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report. 2013. WHO Report 2013. WHO/HTM/TB/2013.11: WHO, Geneva; 2013
   Google Scholar
• Montagnani C, Chiappini E, Galli L, de Martino M. Vaccine against tuberculosis: what’s new? BMC Infect Dis 2014;14(Suppl 1):S2
   PubMed Web of Science ®Google Scholar
• Orme IM, Belisle JT. TB vaccine development: after the flood. Trends Microbiol 1999;7(10):394-5
   PubMed Web of Science ®Google Scholar
• Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393(6685):537-44
   PubMed Web of Science ®Google Scholar
• Chaitra MG, Shaila MS, Chandra NR, Nayak R. HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis. Scand J Immunol 2008;67(4):411-17
   PubMed Web of Science ®Google Scholar
• Brennan MJ, Delogu G. The PE multigene family: a ‘molecular mantra’ for mycobacteria. Trends Microbiol 2002;10(5):246-9
   PubMed Web of Science ®Google Scholar
• Chaitra MG, Hariharaputran S, Chandra NR, et al. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential. Vaccine 2005;23(10):1265-72
   PubMed Web of Science ®Google Scholar
• Cascioferro A, Delogu G, Colone M, et al. PE is a functional domain responsible for protein translocation and localization on mycobacterial cell wall. Mol Microbiol 2007;66(6):1536-47
   PubMed Web of Science ®Google Scholar
• Tian C, Jian-Ping X. Roles of PE_PGRS family in Mycobacterium tuberculosis pathogenesis and novel measures against tuberculosis. Microb Pathog 2010;49(6):311-14
   PubMed Web of Science ®Google Scholar
• Copin R, Coscollá M, Seiffert SN, et al. Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition. MBio 2014;5(1):e00960-13
   PubMed Web of Science ®Google Scholar
• Ramakrishnan L, Federspiel NA, Falkow S. Granuloma-specific expression of mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 2000;288(5470):1436-9
   PubMed Web of Science ®Google Scholar
• Espitia C, Laclette JP, Mondragón-Palomino M, et al. The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? Microbiology 1999;145(Pt 12):3487-95
   PubMed Web of Science ®Google Scholar
• Dheenadhayalan V, Delogu G, Brennan MJ. Expression of the PE_PGRS33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival. Microbes Infect 2006;8(1):262-72
   PubMed Web of Science ®Google Scholar
• Brennan MJ, Delogu G, Chen Y, et al. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect Immun 2001;69(12):7326-33
   PubMed Web of Science ®Google Scholar
• Banu S, Honoré N, Saint-Joanis B, et al. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol 2002;44(1):9-19
   PubMed Web of Science ®Google Scholar
• Dheenadhayalan V, Delogu G, Sanguinetti M, et al. Variable expression patterns of Mycobacterium tuberculosis PE_PGRS genes: evidence that PE_PGRS16 and PE_PGRS26 are inversely regulated in vivo. J Bacteriol 2006;188(10):3721-5
   PubMed Web of Science ®Google Scholar
• Delogu G, Sanguinetti M, Pusceddu C, et al. PE_PGRS proteins are differentially expressed by Mycobacterium tuberculosis in host tissues. Microbes Infect 2006;8(8):2061-7
   PubMed Web of Science ®Google Scholar
• Rachman H, Strong M, Ulrichs T, et al. Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect Immun 2006;74(2):1233-42
   PubMed Web of Science ®Google Scholar
• Fleischmann RD, Alland D, Eisen JA, et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol 2002;184(19):5479-90
   PubMed Web of Science ®Google Scholar
• Talarico S, Cave MD, Marrs CF, et al. Variation of the Mycobacterium tuberculosis PE_PGRS33 gene among clinical isolates. J Clin Microbiol 2005;43(10):4954-60
   PubMed Web of Science ®Google Scholar
• Talarico S, Cave MD, Foxman B, et al. Association of Mycobacterium tuberculosis PE_PGRS33 polymorphism with clinical and epidemiological characteristics. Tuberculosis (Edinb) 2007;87(4):338-46
   PubMed Web of Science ®Google Scholar
• Wang J, Huang Y, Zhang A, et al. DNA polymorphism of Mycobacterium tuberculosis PE_PGRS33 gene among clinical isolates of pediatric TB patients and its associations with clinical presentation. Tuberculosis (Edinb) 2011;91(4):287-92
   PubMed Web of Science ®Google Scholar
• Delogu G, Pusceddu C, Bua A, et al. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure. Mol Microbiol 2004;52(3):725-33
   PubMed Web of Science ®Google Scholar
• Delogu G, Brennan MJ. Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect Immun 2001;69(9):5606-11
   PubMed Web of Science ®Google Scholar
• Parra M, Cadieux N, Pickett T, et al. A PE. protein expressed by Mycobacterium avium is an effective T-cell immunogen. Infect Immun 2006;74(1):786-9
   PubMed Web of Science ®Google Scholar
• Basu S, Pathak SK, Banerjee A, et al. Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha. J Biol Chem 2007;282(2):1039-50
   PubMed Web of Science ®Google Scholar
• Balaji KN, Goyal G, Narayana Y, et al. Apoptosis triggered by Rv1818c, a PE family gene from Mycobacterium tuberculosis is regulated by mitochondrial intermediates in T cells. Microbes Infect 2007;9(3):271-81
   PubMed Web of Science ®Google Scholar
• Singh PP, Parra M, Cadieux N, Brennan MJ. A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins. Microbiology 2008;154(Pt 11):3469-79
   PubMed Web of Science ®Google Scholar
• Sali M, Di Sante G, Cascioferro A, et al. Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice. Infect Immun 2010;78(12):5202-13
   PubMed Web of Science ®Google Scholar
• Cadieux N, Parra M, Cohen H, et al. Induction of cell death after localization to the host cell mitochondria by the Mycobacterium tuberculosis PE_PGRS33 protein. Microbiology 2011;157(Pt 3):793-804
   PubMed Web of Science ®Google Scholar
• Moreno-Altamirano MM, Paredes-González IS, Espitia C, et al. Bioinformatic identification of Mycobacterium tuberculosis proteins likely to target host cell mitochondria: virulence factors? Microb Inform Exp 2012;2(1):9
   PubMedGoogle Scholar
• Cascioferro A, Daleke MH, Ventura M, et al. Functional dissection of the PE domain responsible for translocation of PE_PGRS33 across the Mycobacterial cell wall. PLoS One 2011;6(11):e27713
   PubMed Web of Science ®Google Scholar
• Zumbo A, Palucci I, Cascioferro A, et al. Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis. Pathog Dis 2013;69(3):232-9
   PubMed Web of Science ®Google Scholar
• Chaitra MG, Shaila MS, Nayak R. Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE _PGRS33 protein of Mycobacterium tuberculosis. J Med Microbiol 2007;56(Pt 4):466-74
   PubMed Web of Science ®Google Scholar
• Chaitra MG, Nayak R, Shaila MS. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Vaccine 2007;25(41):7168-76
   PubMed Web of Science ®Google Scholar
• Chaitra MG, Shaila MS, Nayak R. Detection of interferon gamma-secreting CD8 T lymphocytes in humans specific for three PE/PPE proteins of Mycobacterium tuberculosis. Microbes Infect 2008;10(8):858-67
   PubMed Web of Science ®Google Scholar
• Cohen I, Parada C, Acosta-Gío E, Espitia C. The PGRS domain from PE_PGRS33 of Mycobacterium tuberculosis is target of humoral immune response in mice and humans. Front Immunol 2014;5:236
   PubMed Web of Science ®Google Scholar
• Sampson SL. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin Dev Immunol 2011;2011:497203
   PubMedGoogle Scholar
• Huleatt JW, Jacobs AR, Tang J, et al. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 2007;25(4):763-75
   PubMed Web of Science ®Google Scholar
• Jacobsen M, Mattow J, Repsilber D, Kaufmann SH. Novel strategies to identify biomarkers in tuberculosis. Biol Chem 2008;389(5):487-95
   PubMed Web of Science ®Google Scholar
• Comas I, Chakravartti J, Small PM, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010;42(6):498-503
   PubMed Web of Science ®Google Scholar
• Narayana Y, Joshi B, Katoch VM, et al. Differential B-cell responses are induced by Mycobacterium tuberculosis PE antigens Rv1169c, Rv0978c, and Rv1818c. Clin Vaccine Immunol 2007;14(10):1334-41
   PubMedGoogle Scholar
• Vallecillo AJ, Espitia C. Expression of Mycobacterium tuberculosis PE_PGRS33 is repressed during stationary phase and stress conditions, and its transcription is mediated by sigma factor A. Microb Pathog 2009;46(3):119-27
   PubMed Web of Science ®Google Scholar